Michigan Radiation Oncology Quality Consortium (MROQC)
Melissa Mietzel, MS, has a background in managing oncology trials and clinical research at prestigious healthcare institutions. Melissa currently serves as a Program Manager at the Michigan Radiation Oncology Quality Consortium (MROQC), where Melissa oversees the clinical data registry for patients receiving radiation treatment. Prior to this role, Melissa held positions at Michigan Medicine, University of Michigan Medical School, Loyola University Health System, and University of Chicago Hospitals, gaining extensive experience in coordinating research trials in various medical specialties. Melissa holds a Bachelor of Science in Human Biology from Michigan State University and a Master of Science in Medical Sciences from Wayne State University School of Medicine.
This person is not in the org chart
Michigan Radiation Oncology Quality Consortium (MROQC)
The Michigan Radiation Oncology Quality Consortium (MROQC) was established in 2011, through the generous support from Blue Cross Blue Shield of Michigan and Blue Care Network. In this first-of-its-kind collaborative quality initiative (CQI), MROQC has created a comprehensive clinical data registry of patients receiving radiation treatment for breast, lung, and prostate cancers and bone metastases. Our registry is maintained by the MROQC Coordinating Center and includes both patient-reported outcomes and physician assessments of toxicity as well as data on radiation treatment delivery and dose.